HeartSciences Inc.

Contributing Author

Recent Articles by HeartSciences Inc.

Oct-21	HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining HSCS +13.74% GlobeNewswire
Oct-06	HeartSciences Receives FDA 510(k) Clearance for its MyoVista wavECGTM Device HSCS -13.53% GlobeNewswire
Sep-15	HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update HSCS GlobeNewswire
Aug-19	Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration HSCS +19.48% GlobeNewswire
Jul-29	HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results HSCS GlobeNewswire
Jul-23	HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K HSCS GlobeNewswire
Jun-11	European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents HSCS GlobeNewswire
Jun-02	HeartSciences Launches MyoVista Insights Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm HSCS GlobeNewswire
May-19	HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network HSCS GlobeNewswire
May-05	HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights HSCS GlobeNewswire
Apr-14	HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting HSCS GlobeNewswire
Mar-25	HeartSciences' MyoVista Insights Receives Epic Toolbox Designation for ECG Management System Category HSCS GlobeNewswire
Mar-24	HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings HSCS GlobeNewswire
Mar-16	HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update HSCS GlobeNewswire
Feb-05	University of West England Adopts HeartSciences' MyoVista Insights Platform and MyoVista wavECG Device to Establish ECG Education and Technology Reference Center HSCS GlobeNewswire
Jan-29	Cibolo Health Designates HeartSciences' MyoVista Insights as Endorsed ECG Management Platform for Network of 123 Independent Hospitals HSCS GlobeNewswire
Dec-15	HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update HSCS HSCS -6.48% GlobeNewswire
Dec-15	HeartSciences Announces FDA 510(k) Submission for MyoVista wavECG Device HSCS GlobeNewswire
Dec-11	HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 HSCS GlobeNewswire
Sep-11	HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results HSCS HSCS -10.03% GlobeNewswire
Aug-15	HeartSciences Announces Conference Participation and Investor Webinar HSCS GlobeNewswire
Jul-24	HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results HSCS GlobeNewswire
Jun-04	HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis HSCS GlobeNewswire
Jun-03	Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value HSCS +6.78% GlobeNewswire
May-29	HeartSciences Signs First MyoVista Insights Platform Customer, Marking Major Commercial Milestone HSCS GlobeNewswire

HeartSciences Inc.

Recent Articles by HeartSciences Inc.

Upgrade your Finviz experience